India to Nigeria: Erythromycin Export Trade Route

The India to Nigeria Erythromycin corridor is one of India's established pharmaceutical export routes, with 100 shipments documented worth a combined $4.7M USD. The route is dominated by GLOBELA PHARMA PRIVATE LIMITED, which alone accounts for roughly 19% of all export value, reflecting the consolidated nature of India's erythromycin manufacturing sector.

Across 27 active suppliers, the average shipment value stands at $47.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with erythromycin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 22.8%, placing it at rank #6 among India's top erythromycin export destinations globally.

On the import side, key buyers of Indian erythromycin in Nigeria include EVERDESTINY PHARMACEUTICALS LIMITED, TO THE ORDER OF PORT OF DISCHARGE, GLOBAL YOUNG PHARMA LTD, and 41 others. EVERDESTINY PHARMACEUTICALS LIMITED is the single largest importer with 6 shipments valued at $628.5K USD.

India's erythromycin exports to Nigeria are driven primarily by a handful of large-scale manufacturers. GLOBELA PHARMA PRIVATE LIMITED with 11 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 27 active exporters signals a competitive but concentrated market — buyers in Nigeria benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GLOBELA PHARMA PRIVATE LIMITED, CLAROID PHARMACEUTICALS PRIVATE LIMITED, ALPA LABORATORIES LIMITED — together account for 43% of total trade value on this route. The average shipment value of $47.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as erythromycin stearate tablets bp 500 mg and eryaporo (erythromycin stearate tablets, suggesting that buyers in Nigeria tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, EVERDESTINY PHARMACEUTICALS LIMITED is the largest importer with 6 shipments worth $628.5K USD — representing 13% of all erythromycin imports from India on this route. A total of 44 buyers are active on this corridor.